CDMO Partnerships

Webinar: A Developer's Guide to Partnering With the Right CDMO, Presented by Samsung Biologics

Samsung Biologics

Combining RNA Splicing and AI Technologies to Accelerate Drug Discovery and Development

Martin Akerman, Ph.D.

Envisagenics

Plant-Inspired Drug Discovery

Unlocking the Therapeutic Potential of Plant-Inspired Minimum Essential Mixtures

Andrea Small-Howard, Ph.D.

Gb Sciences, Inc.

Series C Funding

BenchSci Raises $63 Million Series C to Solve Pharma's Biggest R&D Challenges with AI-Powered Software Platform

BenchSci

Precision Medicine

Profiling Cancer Genetics to Enable Precision Therapies

Razelle Kurzrock, MD

Construction

How Agile Construction Practices Can Help Bring New Drugs and Vaccines to Market

Damien Gallogly

Immunotherapy

Using a Natural Molecular Warning System to Fight Cancer and Infectious Diseases

Jeff Wolf

Heat Biologics

Drug Development

Analysis Finds Big Pharma Does Not Develop Most New Drugs

Cynthia A. Challener, Ph.D.

Pharma's Almanac

Cell and Gene Therapy

Takeda Collaborates on Gene Therapy Development

David Alvaro, Ph.D.

Pharma's Almanac

Launch

Seqens Cosmetics, Functional Care (formerly Chemoxy), Launches ChemoxyCare® 6, 1,2- Hexanediol with Best in Class Quality Profile

Seqens

Big Data

The Evolution of Pharma Depends on Data Integration and Application

Nigel Walker

Nice Insight

Big Data

Big Data in Drug Development and Discovery

Cynthia A. Challener, Ph.D.; Emilie Branch; David Alvaro, Ph.D.

Pharma's Almanac

Drug Development

Bacteria in the Stomach Found to Play a Role in Multiple Sclerosis

Emilie Branch

Pharma's Almanac

Diagnostics

Researchers Develop Diagnostic for Rare Cancer-Generated Glycoproteins

Emilie Branch

Pharma's Almanac

Cell and Gene Therapy

Editas Founders Start New Gene Editing Company

Emilie Branch

Pharma's Almanac

CRISPR

CRISPR Gene Editing Technology Could Eliminate the Need for Hemophilia B Sufferers to Receive Ongoing Injections

Nigel Walker

Nice Insight

Antibiotics

Macrolide Attracts Funding and Executive Talent

Nigel Walker

Nice Insight

Cell-Line

Compugen Has Licensed Selexis’ Cell Line-Based Protein Expression Platform for the Development of Antibody-Based Therapeutics

Selexis SA

Drug Development

New Real-World Analysis Finds Lower Risk of Major Bleeding and Similar Risk of Stroke with Standard Dose of Pradaxa® Compared to Rivaroxaban

Boehringer Ingelheim

Drug Development

Janssen to Present 14 Abstracts in Prostate and Urothelial Cancers at ASCO GU 2018

Janssen Pharmaceutical Companies